Dr. Jean-Christophe Leroux is Professor in Drug Formulation and Delivery at ETH Zurich. His research interests include the design of novel biopolymers, stimuli-responsive drug delivery systems (liposomes, micelles and gels) and the targeting of anticancer drugs. Recently he has been involved in the development of polymer therapeutics for Celiac disease. He is the author or coauthor of numerous refereed articles, book chapters and patents/patent applications in the field of drug delivery. He serves in the editorial board of several journals including the Journal of Controlled Release and Molecular Pharmaceutics. He has received several prestigious distinctions and fellowships including the CRS-Capsugel (1997 and 2003), AFPC-Astra Zeneca (2003) and CRS young investigator awards (2004) and the Steacie Fellowships (2008) for innovative research in pharmaceutical technology.
On behalf of Liposome Research Days (LRD) 2022 we are pleased to invite all interested parties to our meeting Catalyzing the Nanomedicine Revolution, June 12-15, 2022 at the University of British Columbia (UBC) in Vancouver, Canada.
Leading international experts will deliver overview lectures that provide a global perspective, and will be available to network with fellow experts, academics and trainees. Researchers and trainees from academia and industry will present the latest research on key topics such as vaccines, gene therapy, gene editing, chemotherapy, and lipid and membrane biophysics.
The conference will take place on the beautiful UBC Campus in Vancouver and promises to be one of the most important nanomedicine conferences of the year.
On behalf of Liposome Research Days (LRD) 2022 we are pleased to invite all interested parties to our meeting Catalyzing the Nanomedicine Revolution, June 12-15, 2022 at the University of British Columbia (UBC) in Vancouver, Canada.
Leading international experts will deliver overview lectures that provide a global perspective, and will be available to network with fellow experts, academics and trainees. Researchers and trainees from academia and industry will present the latest research on key topics such as vaccines, gene therapy, gene editing, chemotherapy, and lipid and membrane biophysics.
The conference will take place on the beautiful UBC Campus in Vancouver and promises to be one of the most important nanomedicine conferences of the year.
On behalf of Liposome Research Days (LRD) 2022 we are pleased to invite all interested parties to our meeting Catalyzing the Nanomedicine Revolution, June 12-15, 2022 at the University of British Columbia (UBC) in Vancouver, Canada.
Leading international experts will deliver overview lectures that provide a global perspective, and will be available to network with fellow experts, academics and trainees. Researchers and trainees from academia and industry will present the latest research on key topics such as vaccines, gene therapy, gene editing, chemotherapy, and lipid and membrane biophysics.
The conference will take place on the beautiful UBC Campus in Vancouver and promises to be one of the most important nanomedicine conferences of the year.
On behalf of Liposome Research Days (LRD) 2022 we are pleased to invite all interested parties to our meeting Catalyzing the Nanomedicine Revolution, June 12-15, 2022 at the University of British Columbia (UBC) in Vancouver, Canada.
Leading international experts will deliver overview lectures that provide a global perspective, and will be available to network with fellow experts, academics and trainees. Researchers and trainees from academia and industry will present the latest research on key topics such as vaccines, gene therapy, gene editing, chemotherapy, and lipid and membrane biophysics.
The conference will take place on the beautiful UBC Campus in Vancouver and promises to be one of the most important nanomedicine conferences of the year.